Menu

2026 Speakers

Meet the global experts, regulators, researchers, industry leaders, and patient advocates shaping the future of paediatric drug development. Browse the speakers below and discover the voices joining us at BMFC2026 to drive innovation in medicines for children.

Keynote Speakers

Tomasz Grybek
Paediatric Committee (PDCO), European Medicines Agency | EURORDIS – Rare Diseases Europe
Rieke van der Graaf
Julius Center, UMC Utrecht | WHO Collaborating Center for Bioethics

Session Speakers

Catherine Tuleu
UCL School of Pharmacy
Covadonga Terol Espinosa de los Monteros
Paediatric Medicines Office, European Medicines Agency
Ellen Koekoeckx
Foundation for Angelman Syndrome Therapeutics (FAST)
Gloria Garcia Palacios
Sanofi
Jana Lass
Tartu University Hospital | University of Tartu
Joana Claverol
Sant Joan de Déu Barcelona Children’s Hospital (Spain)
Lise Carle Empereur
UCB Pharma
María Baselga
Rare Diseases Advocate/Patient Voice
Monique Al
COMBINE, CTCG
Nicolas Micheaud
Paediatis Pharma SAS
Sabine Scherer
German Federal Institute for Drugs and Medical Devices (BfArM)

Session Moderators

Angelika Joos
EFGCP
Angeliki Siapkara
AstraZeneca
Begonya Nafria Escalera
Barcelona Children’s Hospital, eYPAGnet & EFGCP
Claudio Fracasso
Hippocrates Research Srl
Donato Bonifazi
TEDDY – European Network of Excellence for Paediatric research
Gesine Bejeuhr
Bayer
Jasmine Kincaide
Bayer
Martine Dehlinger-Kremer
UCB
Mette Due Theilade Thomsen
PIP Adviser ApS
Pauline Roudot
Novartis
Ricardo Fernandes
conect4children-Stichting
Sabine Fürst-Recktenwald
Novartis
Solange Corriol Rohou